Technical Analysis for AMPH - Amphastar Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 19.95 -0.40% -0.08
AMPH closed down 0.4 percent on Thursday, July 18, 2019, on 56 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AMPH trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Multiple of Ten Bullish Other -0.40%
BB Squeeze Ended Range Expansion -0.40%
Down 3 Days in a Row Weakness -0.40%
Shooting Star Candlestick Bearish -0.70%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.70%
Bollinger Band Squeeze Range Contraction -0.70%
Bollinger Band Squeeze Range Contraction -1.19%

Older signals for AMPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company's products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl Injection for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose; and Phytonadione Injection (Vitamin K1) for newborns. In addition, it markets its drug development pipeline and patented technologies. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California with manufacturing subsidiaries/facilities in South El Monte, California; and West Roxbury and Canton, Massachusetts.
Medicine Chemistry Pharmaceutical Pharmaceutical Products Pharmacology Medical Equipment Drug Development Active Pharmaceutical Ingredients Syringe Deep Vein Thrombosis Drug Paraphernalia Injection Heroin Hyaluronidase Lidocaine
Is AMPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.43
52 Week Low 16.18
Average Volume 170,573
200-Day Moving Average 20.9571
50-Day Moving Average 20.62
20-Day Moving Average 20.528
10-Day Moving Average 20.239
Average True Range 0.5266
ADX 19.4
+DI 15.4322
-DI 27.5734
Chandelier Exit (Long, 3 ATRs ) 19.9902
Chandelier Exit (Short, 3 ATRs ) 21.1898
Upper Bollinger Band 21.3787
Lower Bollinger Band 19.6773
Percent B (%b) 0.16
BandWidth 8.288192
MACD Line -0.145
MACD Signal Line -0.0703
MACD Histogram -0.0747
Fundamentals Value
Market Cap 921.59 Million
Num Shares 46.2 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 249.38
Price-to-Sales 3.41
Price-to-Book 2.55
PEG Ratio 2.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.39
Resistance 3 (R3) 20.39 20.26 20.31
Resistance 2 (R2) 20.26 20.15 20.25 20.29
Resistance 1 (R1) 20.10 20.08 20.04 20.10 20.26
Pivot Point 19.97 19.97 19.93 19.96 19.97
Support 1 (S1) 19.81 19.86 19.75 19.81 19.64
Support 2 (S2) 19.68 19.79 19.67 19.61
Support 3 (S3) 19.52 19.68 19.59
Support 4 (S4) 19.52